Huanle Pan

891 total citations · 1 hit paper
10 papers, 698 citations indexed

About

Huanle Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Huanle Pan has authored 10 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Huanle Pan's work include Bioactive Compounds and Antitumor Agents (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Circular RNAs in diseases (2 papers). Huanle Pan is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Circular RNAs in diseases (2 papers). Huanle Pan collaborates with scholars based in China and United States. Huanle Pan's co-authors include Congying Xie, Xiance Jin, Lanxiao Shen, Huafang Su, Lihao Zhao, Deyao Xie, Baochai Lin, Didi Chen, Shaoran Fei and Yanfan Chen and has published in prestigious journals such as Clinical Cancer Research, Molecular Cancer and European Journal of Pharmacology.

In The Last Decade

Huanle Pan

8 papers receiving 694 citations

Hit Papers

Evaluation of Tumor-Derived Exosomal miRNA as Potential D... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanle Pan China 7 606 531 67 63 41 10 698
Yayun Cui China 11 345 0.6× 277 0.5× 47 0.7× 80 1.3× 41 1.0× 28 459
Rogelio Montiel-Manríquez Mexico 5 365 0.6× 321 0.6× 58 0.9× 30 0.5× 30 0.7× 8 461
Linger Liu China 3 388 0.6× 364 0.7× 59 0.9× 45 0.7× 37 0.9× 5 469
Shaoran Fei China 5 390 0.6× 363 0.7× 90 1.3× 53 0.8× 38 0.9× 5 486
Junmi Lu China 13 368 0.6× 268 0.5× 82 1.2× 71 1.1× 18 0.4× 23 487
Yihang Guo China 13 347 0.6× 263 0.5× 46 0.7× 53 0.8× 20 0.5× 31 444
Jiaqi Yin China 8 389 0.6× 325 0.6× 88 1.3× 82 1.3× 27 0.7× 20 525
Xiaobing Qin China 12 448 0.7× 355 0.7× 77 1.1× 127 2.0× 29 0.7× 30 613
Zhengran Jiang United States 7 436 0.7× 377 0.7× 78 1.2× 175 2.8× 32 0.8× 8 601

Countries citing papers authored by Huanle Pan

Since Specialization
Citations

This map shows the geographic impact of Huanle Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanle Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanle Pan more than expected).

Fields of papers citing papers by Huanle Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanle Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanle Pan. The network helps show where Huanle Pan may publish in the future.

Co-authorship network of co-authors of Huanle Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Huanle Pan. A scholar is included among the top collaborators of Huanle Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanle Pan. Huanle Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Pan, Huanle, Xiaobo Zhou, Lanxiao Shen, et al.. (2023). Efficacy of apatinib+radiotherapy vs radiotherapy alone in patients with advanced multiline therapy failure for non small cell lung cancer with brain metastasis. British Journal of Radiology. 96(1149). 20220550–20220550.
3.
Cai, Yixin, Yiqing Wu, Jie Liu, et al.. (2023). Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study. BMC Cancer. 23(1). 1188–1188. 5 indexed citations
4.
Yu, Yun, Tao Wu, Xiaodong Zhang, et al.. (2023). Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells. European Journal of Pharmacology. 957. 175986–175986. 8 indexed citations
6.
Wu, Fengjiao, Peisen Zheng, Tingting Zhang, et al.. (2022). Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage. Frontiers in Oncology. 12. 813854–813854. 8 indexed citations
7.
Gao, Ya, Xinyi Wu, Yifei Li, et al.. (2020). <p>The Predictive Value of MLR for Radiation Pneumonia During Radiotherapy of Thoracic Tumor Patients</p>. Cancer Management and Research. Volume 12. 8695–8701. 8 indexed citations
8.
Jin, Xiance, Yanfan Chen, Hanbin Chen, et al.. (2017). Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing. Clinical Cancer Research. 23(17). 5311–5319. 437 indexed citations breakdown →
9.
Su, Huafang, Xia Deng, Lanxiao Shen, et al.. (2016). Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells. Journal of Translational Medicine. 14(1). 225–225. 159 indexed citations
10.
Su, Huafang, Xiance Jin, Xuebang Zhang, et al.. (2015). FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R. Journal of Translational Medicine. 13(1). 104–104. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026